General Information of the Compound
Compound ID |
CP0034701
|
||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Compound Name |
N-[2-(5-methoxy-1H-indol-3-yl)ethyl]acetamide
Show/Hide
|
||||||||||||||||||
Synonyms |
Circadin
4-ACETAMIDO-4'-ISOTHIO-CYANATOSTILBENE-2,2'-DISULFONIC ACID
5-Methoxy-N-acetyltryptamine
73-31-4
Acetamide, N-(2-(5-methoxy-1H-indol-3-yl)ethyl)-(9CI)
Acetamide, N-(2-(5-methoxyindol-3-yl)ethyl)-
Acetamide, N-[2-(5-methoxy-1H-indol-3-yl)ethyl]-
Acetamide, N-[2-(5-methoxy-1H-indol-3-yl)ethyl]-(9CI)
Acetamide, N-[2-(5-methoxyindol-3-yl)ethyl]-(6CI,8CI)
Acetamide, {N-[2-(5-methoxy-1H-indol-3-yl)ethyl]-}
Acetamide, {N-[2-(5-methoxyindol-3-yl)ethyl]-}
BRN 0205542
CCRIS 3472
CHEMBL45
Circadin
EINECS 200-797-7
IN1244
JL5DK93RCL
M 5250
M-1200
M-1250
M1105
ML1
MT6
Mela-T
Melapure
Melatol
Melatonex
Melatonex, Melatonin
Melatonin
Melatonina
Melatonina (TN)
Melatonine
Melovine
N-(2-(5-Methoxy-1H-indol-3-yl)ethyl)acetamide
N-(2-(5-Methoxyindol-3-yl)ethyl)acetamide
N-Acetyl-5-methoxytryptamine
N-[2-(5-Methoxy-1H-indol-3-yl)-ethyl]-acetamide
N-[2-(5-Methoxy-1H-indol-3-yl)ethyl]acetamide
N-[2-(5-methoxy-1H-indol-3-yl)ethyl]acetamide
N-[2-(5-methoxyindol-3-yl)ethyl]acetamide
N-acetyl-5-methoxy-tryptamine
NMR/14327425
NSC 113928
Nature'S Harmony
Night Rest
PREVENTION 1 (MELATONIN) (PREVENTION 1)
PREVENTION 2 (MELATONIN)
PREVENTION 3 (MELATONIN)
PREVENTION 4 (MELATONIN)
PREVENTION 5 (MELATONIN)
Pineal Hormone
Posidorm
Revital Melatonin
Rx Balance
Sleep Right
TNP00300
UNII-JL5DK93RCL
Vivitas
[3H]melatonin
Show/Hide
|
||||||||||||||||||
Structure |
|
||||||||||||||||||
Formula |
C13H16N2O2
|
||||||||||||||||||
Molecular Weight |
232.283
|
||||||||||||||||||
Canonical SMILES |
COc1ccc2[nH]cc(CCNC(C)=O)c2c1
Show/Hide
|
||||||||||||||||||
InChI |
InChI=1S/C13H16N2O2/c1-9(16)14-6-5-10-8-15-13-4-3-11(17-2)7-12(10)13/h3-4,7-8,15H,5-6H2,1-2H3,(H,14,16)
Show/Hide
|
||||||||||||||||||
InChIKey |
DRLFMBDRBRZALE-UHFFFAOYSA-N
|
||||||||||||||||||
CAS |
73-31-4
|
||||||||||||||||||
Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
PubChem ID | |||||||||||||||||||
ChEMBL ID | |||||||||||||||||||
DrugBank ID |
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT06109, Geminin
Protein ID: PT01194, Histamine H3 receptor
Protein ID: PT01843, Melatonin receptor type 1A
Cell-based Assay
Protein ID: PT02174, Melatonin receptor type 1B
Cell-based Assay
Protein ID: PT02130, Ribosyldihydronicotinamide dehydrogenase [quinone]
Clinical Information about the Compound
Drug 1 ( Melatonin )
Drug Name | Melatonin | ||
---|---|---|---|
Indication | |||
Target(s) |
Melatonin receptor type 1A (MTNR1A)
Binder
|